Chenguang Biotech Group (300138.SZ) released the third quarter report for 2024, with the company's revenue for the first three quarters of the year amounting to 5...
Zhitong Finance and Economics APP news, Chenguang Biotech Group (300138.SZ) released the third quarter report for 2024, with the company's revenue for the first three quarters reaching 5.225 billion yuan, a year-on-year increase of 1.08%. Net income attributable to shareholders of the listed company was 62.6059 million yuan, a decrease of 84.28% year-on-year. Net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 14.5527 million yuan, a decrease of 95.53% year-on-year. Basic earnings per share were 0.12 yuan.